The NCL MOC aims to provide strategic medicines optimisation leadership across North Central London (NCL) by sharing work and decision making between primary care, secondary care, tertiary care, community care, and social care;
The NCL MOC will work as a subgroup of the NCL Joint Formulary Committee and share information to support the evidence-based, best-value, consistent use of existing medicines, and managed entry of new drugs across NCL.
The NCL MOC aims to identify opportunities to improve safety, patient care and experience through medicines optimisation in all sectors that medicines are used in NCL.
Our Terms of Reference (ToR), Medicines Optimisation Strategy, Processes and Prescribing Policies are also provided.